Cargando…

Prevalence of high‐risk human papillomavirus after HPV‐vaccination in Denmark

Vaccination against human papillomavirus (HPV) has been introduced as a public health initiative in many countries, including Denmark since October 2008. It is important to monitor postimplementation effectiveness of HPV‐vaccination at the population‐level. We studied HPV‐prevalence after first invi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lynge, Elsebeth, Thamsborg, Lise, Larsen, Lise Grupe, Christensen, Jette, Johansen, Tonje, Hariri, Jalil, Christiansen, Sanne, Rygaard, Carsten, Andersen, Berit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2020
Materias:	Cancer Therapy and Prevention
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689747/ https://www.ncbi.nlm.nih.gov/pubmed/32542644 http://dx.doi.org/10.1002/ijc.33157

Ejemplares similares

Danish method study on cervical screening in women offered HPV vaccination as girls (Trial23): a study protocol
por: Thamsborg, Lise Holst, et al.
Publicado: (2018)

Impact of HPV vaccination on outcome of cervical cytology screening in Denmark—A register‐based cohort study
por: Thamsborg, Lise Holst, et al.
Publicado: (2018)

Histological outcomes in HPV-screened elderly women in Denmark
por: St-Martin, Gry, et al.
Publicado: (2021)

High‐grade cervical lesions after vaccination against human papillomavirus: A Danish cohort study
por: Thamsborg, Lise Holst, et al.
Publicado: (2020)

A cervical screening initiative for elderly women in Denmark
por: Skorstengaard, Malene, et al.
Publicado: (2023)

Human papillomavirus‐based screening at extended intervals missed fewer cervical precancers than cytology in the HPV For Cervical Cancer (HPV FOCAL) trial
por: Gottschlich, Anna, et al.
Publicado: (2022)

Stronger responders—uptake and decline of HPV-vaccination in Denmark
por: Lübker, Charlotte Lynderup, et al.
Publicado: (2019)

HPV prevalence and genotype distribution in a population-based split-sample study of well-screened women using CLART HPV2 Human Papillomavirus genotype microarray system
por: Bonde, Jesper, et al.
Publicado: (2014)

Radiosensitization approaches for HPV‐positive and HPV‐negative head and neck squamous carcinomas
por: Dok, Rüveyda, et al.
Publicado: (2019)

Prevalence of Human Papillomavirus in 5,072 Consecutive Cervical SurePath Samples Evaluated with the Roche Cobas HPV Real-Time PCR Assay
por: Preisler, Sarah, et al.
Publicado: (2013)

Cervical cancer risk in HPV‐positive women after a negative FAM19A4/mir124‐2 methylation test: A post hoc analysis in the POBASCAM trial with 14 year follow‐up
por: De Strooper, Lise M.A., et al.
Publicado: (2018)

Effectiveness of the AS04‐adjuvanted HPV‐16/18 vaccine in reducing oropharyngeal HPV infections in young females—Results from a community‐randomized trial
por: Lehtinen, Matti, et al.
Publicado: (2019)

Human papillomavirus self‐sampling with mRNA testing benefits routine screening
por: Auvinen, Eeva, et al.
Publicado: (2022)

Differential Detection of Human Papillomavirus Genotypes and Cervical Intraepithelial Neoplasia by Four Commercial Assays
por: Rebolj, Matejka, et al.
Publicado: (2016)

Human Papillomavirus Assays and Cytology in Primary Cervical Screening of Women Aged 30 Years and Above
por: Rebolj, Matejka, et al.
Publicado: (2016)

Awareness and knowledge of Human Papillomavirus (HPV), HPV‐related cancers, and HPV vaccines in an uninsured adult clinic population
por: Radecki Breitkopf, Carmen, et al.
Publicado: (2016)

Disagreement between Human Papillomavirus Assays: An Unexpected Challenge for the Choice of an Assay in Primary Cervical Screening
por: Rebolj, Matejka, et al.
Publicado: (2014)

Now or later: Health impacts of delaying single‐dose HPV vaccine implementation in a high‐burden setting
por: Burger, Emily A., et al.
Publicado: (2022)

Initial results of population based cervical cancer screening program using HPV testing in one million Turkish women
por: Gultekin, Murat, et al.
Publicado: (2017)

Cross-reactivity profiles of hybrid capture II, cobas, and APTIMA human papillomavirus assays: split-sample study
por: Preisler, Sarah, et al.
Publicado: (2016)

Reliable identification of women with CIN3+ using hrHPV genotyping and methylation markers in a cytology‐screened referral population
por: Leeman, Annemiek, et al.
Publicado: (2018)

Impact of chronic diseases on effect of breast cancer screening
por: Beau, Anna‐Belle, et al.
Publicado: (2020)

Clinical validation of p16/Ki‐67 dual‐stained cytology triage of HPV‐positive women: Results from the IMPACT trial
por: Wright, Thomas C., et al.
Publicado: (2021)

Cervical histology after routine ThinPrep or SurePath liquid-based cytology and computer-assisted reading in Denmark
por: Rebolj, Matejka, et al.
Publicado: (2015)

The impact of HPV vaccination on future cervical screening: a simulation study of two birth cohorts in Denmark
por: Hestbech, Mie Sara, et al.
Publicado: (2015)

Prior human papillomavirus‐16/18 AS04‐adjuvanted vaccination prevents recurrent high grade cervical intraepithelial neoplasia after definitive surgical therapy: Post‐hoc analysis from a randomized controlled trial
por: Garland, Suzanne M., et al.
Publicado: (2016)

Geography of COVID-19 in Denmark
por: Holmager, Therese Lf, et al.
Publicado: (2020)

Late toxicity comparison of alkylating‐based maintenance regimen with cyclophosphamide (VAC) vs ifosfamide (VAI) in Ewing sarcoma survivors treated in the randomized clinical trial Euro‐EWING99‐R1 in France
por: Corvest, Victoria, et al.
Publicado: (2022)

Recent Developments in Human Papillomavirus (HPV) Vaccinology
por: Williamson, Anna-Lise
Publicado: (2023)

Socioeconomic status and risk of lung cancer by histological subtype in the Nordic countries
por: Pizzato, Margherita, et al.
Publicado: (2022)

High incidence of dementia in Faroese‐born female residents in Denmark
por: Petersen, Maria Skaalum, et al.
Publicado: (2020)

Selecting human papillomavirus genotypes to optimize the performance of screening tests among South African women
por: Johnson, Lauren G., et al.
Publicado: (2020)

Prevalence of BRCA1 and BRCA2 pathogenic variants in a large, unselected breast cancer cohort
por: Li, Jingmei, et al.
Publicado: (2018)

Human papillomavirus self‐sampling for screening nonattenders: Opt‐in pilot implementation with electronic communication platforms
por: Lam, Janni Uyen Hoa, et al.
Publicado: (2017)

Knowledge, Attitudes, and Perceptions Towards Human Papillomavirus (HPV) Vaccination Among Adult Women in Primary Health Care Centers in Makkah, Saudi Arabia
por: Turki, Yousef M, et al.
Publicado: (2023)

Allostatic load as predictor of mortality: a cohort study from Lolland-Falster, Denmark
por: Bruun-Rasmussen, Neda Esmailzadeh, et al.
Publicado: (2022)

Serial type-specific human papillomavirus (HPV) load measurement allows differentiation between regressing cervical lesions and serial virion productive transient infections
por: Depuydt, Christophe E, et al.
Publicado: (2015)

Implementation of p16/Ki67 dual stain cytology in a Danish routine screening laboratory: Importance of adequate training and experience
por: Hammer, Anne, et al.
Publicado: (2020)

Distribution of hospital care among pediatric and young adult Hodgkin lymphoma survivors—A population‐based cohort study from Sweden and Denmark
por: Glimelius, Ingrid, et al.
Publicado: (2019)

Selective migration and mortality by economic status in Lolland-Falster, Denmark, 1992–2018
por: Holmager, Therese Lucia Friis, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k5ja7ut3p48gcloag36p8ejmmi